{"id":"W2096850750","doi":"10.1158/1078-0432.ccr-04-0634","title":"Phase II Study of Feasibility of Dose-Dense FEC Followed by Alternating Weekly Taxanes in High-Risk, Four or More Node-Positive Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"Pfizer","keywords":"Medicine; Epirubicin; Regimen; Breast cancer; Surgery; Docetaxel; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001388103,0.0008994335,0.001282671,0.0003517493,0.0003417874,0.0004707952,0.0008589178,0.0008335114,0.001888851],"category_scores_gemma":[0.0009289153,0.000432975,0.0006262879,0.0002881924,0.0008110857,0.000557681,0.0002982387,0.002189263,0.0003094023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006343228,"about_ca_system_score_gemma":0.001399073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007085358,"about_ca_topic_score_gemma":0.001423144,"domain_scores_codex":[0.999584,0.0002037825,0.00002867121,0.00007226519,0.00004139745,0.0000698709],"domain_scores_gemma":[0.9991623,0.0001955073,0.0001781352,0.0001202425,0.00004315273,0.0003006397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4340698,0.2640883,0.01796373,0.0006262115,0.0008172306,0.0005288913,0.0003507861,0.006973824,0.1926549,0.0002703955,0.001056659,0.0805994],"study_design_scores_gemma":[0.1238406,0.8476813,0.009441275,0.00001501478,0.0001825487,0.0003523683,0.00004090956,0.001138827,0.016309,0.00007214231,0.0009107566,0.00001518705],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987671,0.0001982137,0.0001787826,0.00004222315,0.00001724674,0.0005039813,0.00007111875,0.00001329906,0.0002080448],"genre_scores_gemma":[0.9957476,0.0002992747,0.001726447,0.0001297509,0.0000635437,0.001090537,0.0004349503,0.000008645987,0.000499225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001888851,"threshold_uncertainty_score":0.007341087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1348905105525315,"score_gpt":0.5051278133788082,"score_spread":0.3702373028262767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}